Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths

GOP lawmakers call on FDA to increase scrutiny of Chinese clinical trial data after gene therapy deaths

Two Republican members of the House of Representatives are urging the FDA to reject clinical data from China unless trial sites have been recently audited by the agency, following reports of three patient deaths in separate gene therapy clinical trials conducted in China.